LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Abolis joins the EuropaBio 25th Anniversary in 2021

    29/03/2021
    PRESS RELEASE

    Abolis joins the EuropaBio 25th Anniversary in 2021

    Brussels, Belgium – March 29 2021 – EuropaBio today announced that Abolis, a fast-growing French biotech company specialized in enabling the biosynthesis of sustainable molecules for food & feed, cosmetics, flavours & fragrances, specialty chemicals and pharmaceuticals via advanced microbial strain engineering, has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor.

    With a mission to celebrate the most significant scientific and commercial advances in European biotechnology over the last 25 years, Europe’s leading life sciences industry association commenced its quarter century anniversary celebrations in March with the launch of a dedicated website at www.europabio25.org.

    During 2021, EuropaBio, together with its members and partners, will nominate the most impactful cross-sector developments from the last 25 years and showcase how they have benefited society and the environment. The commemoration of 25 years of scientific advances will be amplified through webinars, interviews, and reviews discussing some of the key drivers of biotechnology innovation. The year’s programme of celebratory events will end in December with a gala evening in Brussels and the presenting of the 2021 SME Award from EuropaBio.

    In joining the EuropaBio programme, Abolis will bring its synbio capabilities and its molecular biology, fermentation, robotics and analytics expertise to the celebrations. Abolis will lead the selection committee for industrial biotechnology nominations and also award the delegate-selected prize for best industrial biotech advance in the last 25 years at the EFIB conference in Vienna, in October.

    Dr Claire Skentelbery, Director General of EuropaBio commented, “We are absolutely delighted to welcome Abolis to our 25th anniversary celebrations. It is the perfect example of how Europe builds a competitive future across all sectors from biotechnology.

    “Industrial biotechnology holds the key to a circular bioeconomy and sustainable competitive industry for Europe, which will strongly benefit citizens and producers. They will have access to more sustainably produced ingredients and products and it will be European industry producing them once more” commented Abolis CEO Cyrille Pauthenier. “EuropaBio’s 25th Anniversary is the ideal platform to showcase what biotechnology can deliver and how it will continue to grow”.

    Join in the EuropaBio anniversary celebrations for the whole of 2021 through our newsletter and visit the dedicated Anniversary website at www.europabio25.org.

    Download the full PRESS RELEASE below.

    Abolis joins the EuropaBio 25th Anniversary in 2021


    Download
    2021_03_G_PR_Abolis-Sponsor-for-EuropaBio-25th-AnniversaryDownload
    Share
    Communications Team
    Communications Team

    Related posts

    29/05/2026

    The Luxembourg Institute of Science and Technology joins EuropaBio: Advancing Applied Biotechnology in Europe


    Read more
    26/05/2026

    EuropaBio Position on the Food and Feed SafetyOmnibus (May 2026)


    Read more
    18/05/2026

    Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force


    Read more

    Important links

    • The Luxembourg Institute of Science and Technology joins EuropaBio: Advancing Applied Biotechnology in Europe
    • EuropaBio Position on the Food and Feed SafetyOmnibus (May 2026)

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.